Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent Clostridioides difficile Infection

被引：4
作者：
Chang, Leslie L.
Allegretti, Jessica
Skinner, Andrew M. [1 ,2 ]
Dubberke, Erik R. [3 ]
机构：
[1] Edward Hines Jr Vet Affairs Hosp, Dept Res & Med Edward, Hines, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 388卷 / 07期
关键词：
GUIDELINES; EFFICACY;
D O I：
10.1056/NEJMclde2204692
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Vancomycin to Prevent Recurrent C. difficile Infection This feature about a patient recently treated for C. difficile infection who now needs intravenous antibiotics offers a case vignette accompanied by two essays, one supporting use of oral vancomycin for C. difficile prophylaxis and the other not supporting it.
引用
收藏
页码：654 / 656
页数：3
相关论文
共 9 条
  • [1] Oral vancomycin prophylaxis for the prevention of Clostridium difficile infection: A systematic review and meta-analysis
    Babar, Sumbal
    El Kurdi, Bara
    El Iskandarani, Mahmoud
    Haddad, Ibrahim
    Imam, Zaid
    Alomari, Mohammad
    Myers, James
    Moorman, Jonathan
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (11) : 1302 - 1309
  • [2] Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections
    Carignan, Alex
    Poulin, Sebastien
    Martin, Philippe
    labbe, Annie-Claude
    Valiquette, Louis
    Al-Bachari, Hamed
    Montpetit, Louis-Philippe
    Pepin, Jacques
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12) : 1834 - 1840
  • [3] Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients
    Fishbein, Skye R. S.
    Hink, Tiffany
    Reske, Kimberly A.
    Cass, Candice
    Struttmann, Emily
    Iqbal, Zainab Hassan
    Seiler, Sondra
    Kwon, Jennie H.
    Burnham, Carey-Ann D.
    Dantas, Gautam
    Dubberke, Erik R.
    [J]. MSPHERE, 2021, 6 (01)
  • [4] Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
    Ganetsky, Alex
    Han, Jennifer H.
    Hughes, Mitchell E.
    Babushok, Daria V.
    Frey, Noelle V.
    Gill, Saar I.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Luger, Selina M.
    Mangan, James K.
    Martin, Mary Ellen
    Smith, Jacqueline
    Freyer, Craig W.
    Gilmar, Cheryl
    Schuster, Mindy
    Stadtmauer, Edward A.
    Porter, David L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (12) : 2003 - 2009
  • [5] ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
    Kelly, Colleen R.
    Fischer, Monika
    Allegretti, Jessica R.
    LaPlante, Kerry
    Stewart, David B.
    Limketkai, Berkeley N.
    Stollman, Neil H.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (06) : 1124 - 1147
  • [6] McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]
  • [7] Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile
    Schubert, Alyxandria M.
    Sinani, Hamide
    Schloss, Patrick D.
    [J]. MBIO, 2015, 6 (04):
  • [8] Tomas ME, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.02237-17, 10.1128/AAC.02237-17]
  • [9] Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents
    Van Hise, Nicholas W.
    Bryant, Alex M.
    Hennessey, Erin K.
    Crannage, Andrew J.
    Khoury, Jad A.
    Manian, Farrin A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (05) : 651 - 653
1